166 results
Page 2 of 9
6-K
pkw1m1
21 Dec 22
Current report (foreign)
6:01am
6-K
EX-99.1
to53y cm3uvdlauzqplv
21 Dec 22
Current report (foreign)
6:01am
6-K
31yv6
13 Dec 22
Takeda to Acquire Late-Stage, Potential Best-in-Class, Oral Allosteric TYK2 Inhibitor NDI-034858 From Nimbus Therapeutics
7:00am
6-K
EX-99.1
h1unp
13 Dec 22
Takeda to Acquire Late-Stage, Potential Best-in-Class, Oral Allosteric TYK2 Inhibitor NDI-034858 From Nimbus Therapeutics
7:00am
6-K
oncbv0t
8 Dec 22
Current report (foreign)
6:46am
6-K
zogse4w
4 Nov 22
Current report (foreign)
6:01am
6-K
4me7qm
14 Oct 22
Current report (foreign)
7:36am
6-K
ey2dgmc9be ad975s6e
4 Oct 22
Current report (foreign)
6:06am
6-K
EX-99.1
syhguw0hj7g zn
23 Aug 22
Current report (foreign)
6:13am
6-K
r32iyhsr
4 Aug 22
Current report (foreign)
6:07am
6-K
n6p2pvcnagcbn5d57z4
11 Jul 22
Current report (foreign)
6:05am
6-K
nquqhu o473o
29 Jun 22
Current report (foreign)
6:02am
6-K
7co6i8fecllk6ru9n
24 Jun 22
Current report (foreign)
6:08am
6-K
5ab4yc48ok rbnu1349
10 Jun 22
Current report (foreign)
6:00am
6-K
q8c6rlc
1 Jun 22
Current report (foreign)
6:08am
6-K
pkdax
31 May 22
Current report (foreign)
6:20am
6-K
r0p div2jz2tz
31 May 22
Current report (foreign)
6:18am
6-K
EX-99.1
o1wjlf
31 May 22
Current report (foreign)
6:14am
6-K
EX-99.1
p3xuec
31 May 22
Current report (foreign)
6:07am